跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
KYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSION
Amgen Europe B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 2, 2020
Approval ID
ead80af6f815e2d2
Company
Amgen Europe B.V.
Type
Standard
Approval Details
Approval Id
ead80af6f815e2d2
Drug Cima Aemps Name
KYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSION
Register Number
115106001IP
Holder Company Name
Amgen Europe B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/amgen-europe-b-v
Authorization Date
2020-11-02
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
60 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Amgen Europe B.V.
Company Detail Path
/organization/amgen-europe-b-v
Company Information
Pharmaceutical Company Name
AMGEN EUROPE B.V.
Country Name
Israel
City Name
tel aviv-jaffa,central district,country_il
Address
Simtat Maoz
Active Ingredients
CARFILZOMIB
60 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 2, 2020
Approval ID
ead80af6f815e2d2
Type
Standard
Back to CIMA-AEMPS Approvals
